SCHEMBL7547530

SCHEMBL7547530

COC(=O)c1cccc2c1c(-c1cncc(-c3cccc(Cl)c3)c1)cn2CCCN1CCN(C)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 6/20 0.49
FLT1 P17948 3/20 0.49
FLT4 P35916 3/20 0.49
SMYD2 Q9NRG4 3/20 0.40
BCL2L1 Q07817 1/20 0.40
MCL1 Q07820 1/20 0.40
BAD Q92934 1/20 0.40
CXCR1 P25024 1/20 0.38
AVPR1B P47901 1/20 0.38
GSK3B P49841 3/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
NR4A2 P43354 1/20 0.37
HRH2 P25021 1/20 0.37
HRH1 P35367 1/20 0.37
HRH3 Q9Y5N1 1/20 0.37
QPCT Q16769 2/20 0.37
GRIN1 Q05586 1/20 0.36
GRIN2B Q13224 1/20 0.36
EGFR P00533 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7987672 0.94 KDR (0.47) KDRFLT1FLT4SMYD2BCL2L1
SCHEMBL7551283 0.93 KDR (0.49) KDRFLT1FLT4SMYD2GSK3B
SCHEMBL7554304 0.92 KDR (0.54) KDRFLT1FLT4SMYD2MCL1
SCHEMBL7550186 0.90 KDR (0.49) KDRFLT1FLT4SMYD2MCL1
SCHEMBL7993627 0.89 KDR (0.45) KDRFLT1FLT4SMYD2BCL2L1
SCHEMBL7986724 0.88 FLT1 (0.46) KDRFLT1FLT4BCL2L1MCL1
SCHEMBL7546940 0.88 KDR (0.49) KDRFLT1FLT4SMYD2GSK3B
SCHEMBL7553945 0.87 KDR (0.66) KDRFLT1FLT4SMYD2GSK3B
SCHEMBL7555418 0.86 KDR (0.47) KDRFLT1FLT4SMYD2AVPR1B
SCHEMBL7502702 0.86 KDR (0.46) KDRFLT1BCL2L1MCL1BAD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP claimed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP claimed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO claimed
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP disclosed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP disclosed
US-6265403-B1 TYROSINE INHIBITORS MERCK & CO., INC. 2001-07-24 US disclosed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO disclosed